These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26584032

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox.
    Ei S, Hibi T, Tanabe M, Itano O, Shinoda M, Kitago M, Abe Y, Yagi H, Okabayashi K, Sugiyama D, Wakabayashi G, Kitagawa Y.
    Ann Surg Oncol; 2015 Apr; 22(4):1294-300. PubMed ID: 25287439
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG, Yoon CJ, Jeong SH, Kim JW, Lee SH, Lee KH, Kim YH.
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [Abstract] [Full Text] [Related]

  • 26. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
    Meniconi RL, Komatsu S, Perdigao F, Boëlle PY, Soubrane O, Scatton O.
    Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I.
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [Abstract] [Full Text] [Related]

  • 29. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation.
    Song KD, Lee MW, Rhim H, Kim YS, Kang TW, Shin SW, Cho SK.
    AJR Am J Roentgenol; 2016 Nov; 207(5):1122-1127. PubMed ID: 27575338
    [Abstract] [Full Text] [Related]

  • 30. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K, Asahara T, Ohdan H.
    J Surg Oncol; 2011 Jul 01; 104(1):3-9. PubMed ID: 21656523
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM, Kim JH, Kim EJ, Gwon DI, Ko GY, Ko HK.
    J Vasc Interv Radiol; 2013 Nov 01; 24(11):1639-46. PubMed ID: 23962438
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang Z, Wu M, Chen H, Chen D, He J.
    Zhonghua Wai Ke Za Zhi; 2002 Nov 01; 40(11):826-9. PubMed ID: 12487855
    [Abstract] [Full Text] [Related]

  • 36. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2010 Mar 01; 17(3):869-77. PubMed ID: 20033326
    [Abstract] [Full Text] [Related]

  • 37. Percutaneous thermal ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma ≤5 cm.
    Wu M, Gao S, Song H, Zhang Z, Wang J, Liu R, Wang X, Cheng J, Luo J, Liu Q, Chen Y, Yan Z, Liu L.
    J Cancer Res Ther; 2019 Mar 01; 15(4):766-772. PubMed ID: 31436230
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
    Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY.
    J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991
    [Abstract] [Full Text] [Related]

  • 40. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial.
    Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G.
    J Hepatol; 2014 Dec 01; 61(6):1304-11. PubMed ID: 25064436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.